EODData

FRA, 1XT: XINTELA AB

06 Nov 2025
LAST:

0.0222

CHANGE:
 0.00
OPEN:
0.0222
HIGH:
0.0222
ASK:
0.0000
VOLUME:
0
CHG(%):
11.20
PREV:
0.0250
LOW:
0.0222
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Nov 250.02220.02220.02220.02220
05 Nov 250.02500.02500.02500.0250150
04 Nov 250.02780.02780.02780.0278150
31 Oct 250.02660.02660.02660.0266150
30 Oct 250.02620.03540.02620.0354150
29 Oct 250.02640.02640.02640.0264150
28 Oct 250.02620.02960.02620.0296150
27 Oct 250.02660.03520.02660.035235.0K
24 Oct 250.02640.02640.02640.026435.0K
23 Oct 250.02660.02660.02660.026635.0K

COMPANY PROFILE

Name:XINTELA AB
About:Xintela AB (publ), a biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy. The company's stem cell products include XSTEM, which is in Phase I/IIa clinical development for the treatment of knee osteoarthritis, as well as in clinical study for the treatment of difficult-to-heal leg ulcers, acute respiratory distress syndrome, and other indications; and EQSTEM that is in preclinical development for the treatment of joint disease in horses. It is also developing antibody-based cancer therapies, such as TARG9 and TARG10, which are in preclinical study for the treatment of triple-negative breast cancer and the brain tumor glioblastoma. It has an agreement with Region Östergötland for GMP process development of cell therapy for burn patients. Xintela AB (publ) was incorporated in 2009 and is based in Lund, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:Medicon Village, Lund, Sweden, 223 81
Website:https://www.xintela.se
ISIN:SE0007756903
LEI:549300SMDH1EOLCBQU68

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.40 
Price to Sales:5.80 
Price to Book:-0.90 
Profit Margin:1.00 
Operating Margin:-13.22 
Return on Assets:-1.71 
Return on Equity:6.59 
Revenue:447.4K 
Shares:665.8M 
Market Cap:14.78M 

TECHNICAL INDICATORS

MA5:0.0323.4%
MA10:0.0326.6%
MA20:0.0335.6%
MA50:0.0323.4%
MA100:0.0318.0%
MA200:0.0320.7%
RSI14:44.17
WPR14:-100.00 
MTM14:-0.01
ROC14:-0.21 
ATR:0.00 
Week High:0.0459.5%
Week Low:0.020.0%
Month High:0.05146.8%
Month Low:0.0220.7%
Year High:0.05146.8%
Year Low:0.01122.0%
Volatility:142.68